Position in MRK
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$2,928,772
+$143,939 QoQ
Shares Held
22,792
-1.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#1,353
of 3,766 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MV CAPITAL MANAGEMENT, INC. holds $82,370,025 across 15 Drug Manufacturers - General names. MRK ranks #5 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
271,250 | $68,257,350 | |
| 2 | JNJ |
Johnson & Johnson
|
14,678 | $3,727,771 | |
| 3 | AMGN |
Amgen Inc
|
8,630 | $3,125,095 | |
| 4 | LLY |
ELI LILLY & Co
|
2,477 | $2,970,988 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
22,792 | $2,928,772 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,582 | $957,909 | |
| 7 | PFE |
Pfizer Inc
|
10,065 | $242,365 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,153 | $66,435 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,928,772 | 22,792 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $2,784,833 | 23,151 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,447,189 | 23,249 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $1,925,270 | 22,939 | Shares | Sole | 2026-02-23 | |
| 2025-06-30 | $2,263,580 | 28,595 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,727,267 | 30,384 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $2,752,810 | 27,672 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,152,084 | 27,757 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $3,277,233 | 26,472 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,470,021 | 26,298 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $990,773 | 9,088 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $941,683 | 9,147 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,047,741 | 9,080 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $957,616 | 9,001 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $971,922 | 8,760 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $753,980 | 8,755 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $659,706 | 7,236 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $629,815 | 7,676 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $576,869 | 7,527 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $564,752 | 7,519 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $559,477 | 7,194 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $536,932 | 6,965 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $679,594 | 8,308 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $492,557 | 5,938 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $362,909 | 4,693 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $342,459 | 4,451 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||